Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM
Clinical trial NCT02156791 · COMPLETED
Trial details
- NCT number
- NCT02156791
- Sponsor
- BioTech Tools S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2013-12-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.